This is an old revision of the document!


Innovative Medicines Canada

Member Companies

Lobbying Government

Innovative Medicines Canada lobbies Doug Ford's Government of Ontario through lobbying firm Rubicon Strategy.3) 4) The company seeks to “collaborate with government to ensure ‘Transfer of Value’ Regulations avoid unintended consequences and support a sustainable, balanced and credible approach” surrounding the “Health Sector Payment Transparency ACT”.5)

1)
Member Companies. (2021). Innovative Medicines Canada. http://innovativemedicines.ca/about/member-companies/
2)
Annual Report 2019. Innovative Medicines Canada Annual Report; Innovative Medicines Canada. Retrieved January 2, 2022, from https://www.imcannualreport.ca/download/2019AnnualReviewEN.pdf
3)
Sturgess, L. (2021, December 12). COVID-19 Report #1: Rubicon Strategy. COVID-19 Reports; Substack. https://archive.ph/tSizV
4)
Ronnie. (2021, October 2). Kory Teneycke, Rubicon Strategy, And The Puppets That Are Ford, Kenney & Harper. Canuck Law. https://archive.ph/PC2Th
5)
Letersky, S. (2021, September 22). Consultant Lobbyist Registration No. CL4899-20200917025456. Office of the Integrity Commissioner; Government of Ontario. https://www.campfire.wiki/lib/exe/fetch.php?media=screencapture-lobbyist-oico-on-ca-pages-public-publicsearch-consultantlobbyistpreview-aspx-2022-01-02-12_44_20.pdf
Back to top